In addition to the membrane-bound protein, high levels of circulating endoglin (soluble endoglin; sEng) in plasma from patients with preeclampsia, cancer, or inflammatory-related diseases such as atherosclerosis, psoriasis, or rheumatoid arthritis, has been reported [40,41,43,44,45,46,47]. This evidence concerns the gene ENG and preeclampsia.